期刊文献+

苯丁酸钠联合吉非替尼对NB4细胞生物学活性的影响

The effect of sodium phenylbutyrate combined with gefitinib on the biologic activity of tumor cells
暂未订购
导出
摘要 目的探讨联合应用苯丁酸钠(SPB)与吉非替尼对NB4细胞的抑制效果。方法将NB4细胞随机分成4组,即对照组,SPB组、吉非替尼组、和SPB组+吉非替尼组,细胞生长7d后应用MTT法检测药物对细胞的抑制率,并应用流式细胞仪检测细胞的凋亡情况,应用Westernblot的方法检测p21WAF1、CDK4、野生型p53蛋白的表达,并记录细胞的生长曲线。结果联合用药组肿瘤细胞受到明显抑制,凋亡率增加,p53及p21WAF1表达增加,CDK表达下降。与对照组,SPB组、吉非替尼组相比,差异均有统计学意义(P<0.05)。结论联合用药效果要比单纯用药效果明显,可以使肿瘤细胞受到明显抑制,凋亡率增加,其机制是通过p53依赖的p21WAF1的激活进而抑制周期素-周期素依赖激酶(cyclinD1-CDK4)复合物,从而阻滞了肿瘤细胞的增殖周期进行的。 Objective To investigate the inhibitive effect of sodium phenylbutyrate (SPB) combined with gefitinib on NB4 cells. Methods NB4 ceils were randomly divided into control group, SPB group, gefitinib group and combination group. The inhibitive rate was detected by MTT 7 d after cellular growth, the apoptosis of NB4 was detected by flow cytometry, the expression of P21WAF1, CDK4 and p53 were detected by western blot and the growth curve was recorded. Results The NB4 ceils were suppressed obviously, the rate of apoptosis increased, the expression of p53 and P21WAF1 raised and the expression of CDK4 descended in combination group comparing to those in control, SPB and gefitinib group( P 〈 0.05). Conclusions The curative effect of sodium phenylbutyrate combined with gefitinib is more evident than that of SPB or gefitinib only, the mechanism of which is suppressing cyclinD1-CDK4 complex through activating P21WAFI depended by p53 to blnek proliferation cycle of tumor ceils.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2007年第4期315-317,共3页 Chinese Journal of Gerontology
基金 吉林省计委资助项目(20031268)
关键词 苯丁酸钠 吉非替尼 联合用药 NB4细胞 Sodium phenylbutyrate Gefitinib Combination medication NB4 ceils
  • 相关文献

参考文献5

  • 1Amato RJ.Renal cell carcinoma:review of novel single-agent therapeutics and combination regimens[J].Ann Oncol,2005; 16 (1):7-15.
  • 2孟玫,姜军梅,尹晓燕,朱菊人,秦成勇,郭晓笋.苯丁酸钠对两种人肝癌细胞抑癌基因表达的影响[J].中国药理学通报,2005,21(11):1406-1407. 被引量:4
  • 3高静,栾信庸,许风雷,刘大昱,雷大鹏.苯丁酸钠单用与氟尿嘧啶或顺铂联用对喉癌Hep-2细胞株的影响[J].中国新药与临床杂志,2005,24(10):778-781. 被引量:3
  • 4Jing L,Brahmer J,Messersmith W,et al.Binding of gefitinib,an inhibitor of epidermal growth factor receptor-tyrosine kinase,to plasma proteins and blood cells:in vitro and in cancer patients[J].Invest New Drugs,2006;24(4):291-7.
  • 5Radhakrishnan SK,Gierut J,Gartel AL.Multiple alternate p21 transcripts are regulated by p53 in human cells[J].Oncog,2006;25(12):1812-5.

二级参考文献14

  • 1BRULINA AB, OGIER H, KORALL H, et al. Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients[J]. Mol Genet Metab, 2001, 72(4) : 351-355.
  • 2GORE SD, WENG 1.J, FIGG WD, et al. Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myeledysplastic syndromes and acute myeloid leukemia [ J ]. Clin Cancer Res, 2002, 8(4) : 963-970.
  • 3AMMERPOHL O, THORMEYER D, KHAN Z, et al. HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells[J]. Biochem Biophys Res Commun, 2004, 324(1 ) : 8-14.
  • 4FINZER P, STOHR M, SEIBERT N, et al. Phenylbutyrate inhibits growth of cervical carcinoma cells independent of HPV type and copy number[J]. J Cancer Res Clin Oncal, 2003, 129(2) : 107-113.
  • 5PISCITELLI SC, THIBAULT A, FIGG WD, et al. Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine[J]. J Clin Pharmacol, 1995, 35(4) :368-373.
  • 6DIGIUSEPPE J, WENG L, YU KH, et al. Pheylbutyrate induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis [J]. Leukemia, 1999,13(8): 1243-1253.
  • 7FERRANDINA G, FILIPPINI P, FERLINI C, et al. Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cells [ J ]. Oncol Res, 2000, 12 ( 9-10 ) : 429-440.
  • 8HUANG Y, WAXMAN S. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cell by phenylbutyrate [J]. Clin Cancer Res, 1998, 4(10) : 2503-2509.
  • 9Asklund T, Appelskog IB, Ammerpohl O et al. Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells[J]. Eur J Cancer, 2004,40(7):1073-81.
  • 10Chung YL, Lee YH, Yen SH et al. A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: implications for radiosensitization and EBV-targeted therapy[J]. Clin Cancer Res,2000,6(4):1452-8.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部